The long-term objectives of this work are to use novel technologies to find better ways to diagnose and treat patients with antimalarial drug resistant parasites in India. Drug resistance is a tremendous threat to the treatment of patients, and in P. falciparum, resistance has arisen against all classes of first line anti-malaria drugs. Indeed, several have had to be withdrawn from use in many in countries. Surveillance for drug resistance is a significant challenge, because once enough treatment failures have aroused suspicions of resistance, the spread of resistance is likely to be well advanced. In this project, we propose to use new technologies, including next generation genomics, to study anti-malarial drug resistance in India. Specifically, we will: (1) use new generation sequencing technologies to detect evidence of the eariy signs of failure of ACT in P. falciparum and chloroquine in P. vivax;(2) Develop a non-genetic diagnostic test to identify drug resistance forms of Plasmodium parasites in natural infections;(3) Construct a genetic diversity map of P. vivax in India to determine linkage disequilibrium and provide preliminary data for a haplotype map that can be used for association studies of drug resistance. This project is part of a Center for the Study of Complex Malaria in India (CSCMi). The work, which will be a collaboration between Indian clinicians and epidemiologists, and US-based geneticists and evolutionary biologists, will develop next generation resistance management tools necessary for reducing the burden of both P. falciparum and P. vivax health burdens on the Indian subcontinent.

Public Health Relevance

Malaria is a significant public health burden in India. This project will use cutting-edge genomics technology in an attempt to find better ways to diagnose and treat patients with resistant malaria parasites.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-AWA-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
New York
United States
Zip Code
Hoffmann, Angelika; Wassmer, Samuel C (2018) New Syndromes Identified by Neuroimaging during Cerebral Malaria. Am J Trop Med Hyg 98:349-350
Carlton, Jane M (2018) Malaria parasite evolution in a test tube. Science 359:159-160
Thomas, Shalu; Ravishankaran, Sangamithra; Asokan, Aswin et al. (2018) Socio-demographic and household attributes may not necessarily influence malaria: evidence from a cross sectional study of households in an urban slum setting of Chennai, India. Malar J 17:4
Thomas, Shalu; Ravishankaran, Sangamithra; Justin, N A Johnson Amala et al. (2018) Microclimate variables of the ambient environment deliver the actual estimates of the extrinsic incubation period of Plasmodium vivax and Plasmodium falciparum: a study from a malaria-endemic urban setting, Chennai in India. Malar J 17:201
Huijben, Silvie; Chan, Brian H K; Nelson, William A et al. (2018) The impact of within-host ecology on the fitness of a drug-resistant parasite. Evol Med Public Health 2018:127-137
Carlton, Jane M; Sullivan, Steven A (2017) A Feast of Malaria Parasite Genomes. Cell Host Microbe 21:310-312
Mohanty, Sanjib; Benjamin, Laura A; Majhi, Megharay et al. (2017) Magnetic Resonance Imaging of Cerebral Malaria Patients Reveals Distinct Pathogenetic Processes in Different Parts of the Brain. mSphere 2:
Waite, Jessica L; Swain, Sunita; Lynch, Penelope A et al. (2017) Increasing the potential for malaria elimination by targeting zoophilic vectors. Sci Rep 7:40551
Uplekar, Swapna; Rao, Pavitra Nagesh; Ramanathapuram, Lalitha et al. (2017) Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays. PLoS Negl Trop Dis 11:e0005323
Mooney, Jason Paul; Wassmer, Samuel Crocodile; Hafalla, Julius Clemence (2017) Type I Interferon in Malaria: A Balancing Act. Trends Parasitol 33:257-260

Showing the most recent 10 out of 64 publications